Becton Dickinson/$BDX
1D1W1MYTD1Y5YMAX
About Becton Dickinson
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
- Ticker
- $BDX
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 72,000
- Headquarters
- Franklin Lakes, United States
- Website
- www.bd.com
Becton Dickinson Metrics
BasicAdvanced
$51B
56.30
$3.33
0.26
$4.19
2.24%
Price and volume
Market cap
$51B
Beta
0.26
52-week high
$213.08
52-week low
$140.11
Average daily volume
1.8M
Dividend rate
$4.19
Financial strength
Current ratio
0.865
Quick ratio
0.327
Long term debt to equity
55.337
Total debt to equity
68.84
Dividend payout ratio (TTM)
124.42%
Interest coverage (TTM)
6.23%
Profitability
EBITDA (TTM)
6,466
Gross margin (TTM)
46.94%
Net profit margin (TTM)
4.19%
Operating margin (TTM)
17.85%
Effective tax rate (TTM)
12.29%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
4.75%
Return on equity (TTM)
6.61%
Valuation
Price to earnings (TTM)
56.297
Price to revenue (TTM)
2.351
Price to book
2.09
Price to tangible book (TTM)
-5.35
Price to free cash flow (TTM)
20.481
Free cash flow yield (TTM)
4.88%
Free cash flow per share (TTM)
9.156
Dividend yield (TTM)
2.23%
Forward dividend yield
2.24%
Growth
Revenue change (TTM)
18.49%
Earnings per share change (TTM)
-39.21%
3-year revenue growth (CAGR)
5.69%
10-year revenue growth (CAGR)
6.21%
3-year earnings per share growth (CAGR)
-15.54%
10-year earnings per share growth (CAGR)
-4.43%
3-year dividend per share growth (CAGR)
5.19%
10-year dividend per share growth (CAGR)
4.97%
What the Analysts think about Becton Dickinson
Analyst ratings (Buy, Hold, Sell) for Becton Dickinson stock.
Becton Dickinson Financial Performance
Revenues and expenses
Becton Dickinson Earnings Performance
Company profitability
Becton Dickinson News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.